Compare CSV & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | PSNL |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 686.0M | 729.1M |
| IPO Year | 1996 | 2019 |
| Metric | CSV | PSNL |
|---|---|---|
| Price | $41.75 | $11.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $59.00 | $12.20 |
| AVG Volume (30 Days) | 91.5K | ★ 2.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 54.76 | 33.58 |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $417,440,000.00 | $69,648,000.00 |
| Revenue This Year | $7.35 | $15.34 |
| Revenue Next Year | $3.87 | $41.46 |
| P/E Ratio | $50.55 | ★ N/A |
| Revenue Growth | ★ 3.28 | N/A |
| 52 Week Low | $39.88 | $3.84 |
| 52 Week High | $52.10 | $11.50 |
| Indicator | CSV | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 32.39 | 84.73 |
| Support Level | $40.99 | $6.68 |
| Resistance Level | $44.87 | N/A |
| Average True Range (ATR) | 1.41 | 0.77 |
| MACD | -0.25 | 0.53 |
| Stochastic Oscillator | 0.00 | 92.68 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.